MOSCOW, April 19 – RIA Novosti. The Rapid BIO company (a Skolkovo resident), together with Avivir, registered the first rapid test in Russia to detect antibodies to coronavirus after vaccination, RBC reported.
As specified in the fund, the result of such a study with a reliability of 96 percent will be ready in 15 minutes, and only one drop of blood is needed to conduct it. Skolkovo stressed that the test reagents are validated for vaccines, primarily for Sputnik V.
Earlier, Deputy Prime Minister Tatyana Golikova said that more than eight million people were vaccinated from COVID-19 in Russia. The Ministry of Health has registered three vaccines: Sputnik V, created by the N.F. Gamaleya Center, EpiVacKoronu from the Vector Center under Rospotrebnadzor, and KoviVak from the Chumakov Center of the Russian Academy of Sciences. All three drugs are on the list of essential drugs.
Since the beginning of the pandemic in Russia, more than 4.7 million people have been infected with the coronavirus, over 105 thousand have died, almost 4.4 million have recovered. The spread of the coronavirus